The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life (QOL) analysis from E3805, chemohormonal androgen ablation randomized trial (CHAARTED) in prostate cancer (PrCa).
 
Linda J. Patrick-Miller
No Relationships to Disclose
 
Yu-Hui Chen
No Relationships to Disclose
 
Michael Anthony Carducci
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Blue Earth Diagnostics; Medivation
 
David Cella
Stock and Other Ownership Interests - FACIT.org
Consulting or Advisory Role - Abbvie; Bayer; GlaxoSmithKline; Pfizer
Research Funding - Bayer (Inst); Genentech (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bayer; GlaxoSmithKline
 
Robert S. DiPaola
Research Funding - Abbvie (Inst)
 
Benjamin Adam Gartrell
No Relationships to Disclose
 
David Frazier Jarrard
No Relationships to Disclose
 
Glenn Liu
Stock and Other Ownership Interests - AIQ Solutions
Research Funding - Cellectar (Inst); Johnson & Johnson (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - I have patent pending titled "System and method for evaluation of disease burden" which provides a novel method to identify and quantitate treatment response. (Inst)
Other Relationship - AIQ Solutions
 
Alicia Katherine Morgans
Consulting or Advisory Role - Dendreon; Myriad Genetics
Travel, Accommodations, Expenses - Dendreon; Myriad Genetics
 
Yu-Ning Wong
Research Funding - Bayer (Inst); Medivation (Inst); Millennium (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Tokai Pharmaceuticals
 
Christopher Sweeney
Stock and Other Ownership Interests - BIND Biosciences; Leuchemix
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BIND Biosciences; Genentech/Roche; Janssen Biotech; Sanofi
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Janssen Biotech (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination